RBL1 and retinoblastoma: High-risk alpha E7 represses the retinoblastoma family of tumor suppressors: RB1 (retinoblastoma), RBL1 (p107), and RBL2 (p130); E7 targets the degradation of RB1, which is tied to the cancer phenotype [5].